RECRUITING

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.

Official Title

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Quick Facts

Study Start:2023-09-11
Study Completion:2025-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05874843

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:3 Months to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Known disorder of coagulation pathway(s)
  2. * Administration of medications that may alter the coagulation cascade
  3. * Patients in foster care or wards of the court

Contacts and Locations

Study Contact

Matthew Landman, MD, MPH
CONTACT
317-944-4681
landman@iu.edu

Study Locations (Sites)

Riley Hospital for Children
Indianapolis, Indiana, 46202
United States

Collaborators and Investigators

Sponsor: Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-11
Study Completion Date2025-08

Study Record Updates

Study Start Date2023-09-11
Study Completion Date2025-08

Terms related to this study

Keywords Provided by Researchers

  • thromboelastography

Additional Relevant MeSH Terms

  • Coagulopathy